Heart disease and stroke statistics—2022 update: a report from the American Heart Association
Background: The American Heart Association, in conjunction with the National Institutes of
Health, annually reports the most up-to-date statistics related to heart disease, stroke, and …
Health, annually reports the most up-to-date statistics related to heart disease, stroke, and …
Heart disease and stroke statistics—2023 update: a report from the American Heart Association
CW Tsao, AW Aday, ZI Almarzooq, CAM Anderson… - Circulation, 2023 - Am Heart Assoc
Background: The American Heart Association, in conjunction with the National Institutes of
Health, annually reports the most up-to-date statistics related to heart disease, stroke, and …
Health, annually reports the most up-to-date statistics related to heart disease, stroke, and …
Venous thromboembolism in COVID-19: A systematic review and meta-analysis
A Kollias, KG Kyriakoulis, S Lagou… - Vascular …, 2021 - journals.sagepub.com
Severe coronavirus disease 2019 (COVID-19) is associated with increased risk of venous
thromboembolism events (VTE). This study performed a systematic review in …
thromboembolism events (VTE). This study performed a systematic review in …
[HTML][HTML] Post-acute sequelae of COVID-19: understanding and addressing the burden of multisystem manifestations
Individuals with SARS-CoV-2 infection can develop symptoms that persist well beyond the
acute phase of COVID-19 or emerge after the acute phase, lasting for weeks or months after …
acute phase of COVID-19 or emerge after the acute phase, lasting for weeks or months after …
Thrombotic complications of COVID-19
Introduction The novel coronavirus disease of 2019 (COVID-19) is associated with
significant morbidity and mortality. The impact of thrombotic complications has been …
significant morbidity and mortality. The impact of thrombotic complications has been …
[HTML][HTML] A review on the safety of using JAK inhibitors in dermatology: clinical and laboratory monitoring
C Samuel, H Cornman, A Kambala… - Dermatology and Therapy, 2023 - Springer
Janus kinase (JAK) inhibitors are disease-modifying agents with efficacy in treating a
spectrum of burdensome dermatologic conditions. The US Food and Drug Administration …
spectrum of burdensome dermatologic conditions. The US Food and Drug Administration …
[HTML][HTML] Hypocalcemia in COVID-19: Prevalence, clinical significance and therapeutic implications
COVID-19 extra-pulmonary features include several endocrine manifestations and these are
becoming strongly clinically relevant in patients affected influencing disease severity and …
becoming strongly clinically relevant in patients affected influencing disease severity and …
[HTML][HTML] Persistent endothelial dysfunction in post-acute COVID-19 syndrome: a case-control study
P Ambrosino, I Calcaterra, A Molino, P Moretta… - Biomedicines, 2021 - mdpi.com
Background: Endothelial dysfunction has a key role in the pathogenesis of coronavirus
disease 2019 (COVID-19) and its disabling complications. We designed a case-control …
disease 2019 (COVID-19) and its disabling complications. We designed a case-control …
[HTML][HTML] A rare case of cerebral venous thrombosis and disseminated intravascular coagulation temporally associated to the COVID-19 vaccine administration
V D'Agostino, F Caranci, A Negro, V Piscitelli… - Journal of personalized …, 2021 - mdpi.com
Globally, at the time of writing (20 March 2021), 121.759. 109 confirmed COVID-19 cases
have been reported to the WHO, including 2.690. 731 deaths. Globally, on 18 March 2021, a …
have been reported to the WHO, including 2.690. 731 deaths. Globally, on 18 March 2021, a …
[HTML][HTML] Thrombotic complications in 2928 patients with COVID-19 treated in intensive care: a systematic review
A prothrombotic state is reported with severe COVID-19 infection, which can manifest in
venous and arterial thrombotic events. Coagulopathy is reflective of more severe disease …
venous and arterial thrombotic events. Coagulopathy is reflective of more severe disease …